Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients

Documenti analoghi

• Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
  di: Stevens, R, et al.
  Pubblicazione: (2004)
• Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
  di: Cull, C, et al.
  Pubblicazione: (2007)
• Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations
  di: Ilia Leviev, et al.
  Pubblicazione: (2001-04-01)
• Serum myeloperoxidase, paraoxonase, and plasma asprosin concentrations in patients with acute myocardial infarction
  di: Handan Ciftci, et al.
  Pubblicazione: (2024-04-01)
• UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
  di: Keavney, B, et al.
  Pubblicazione: (1995)